Jupiter Neurosciences
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell JUNS and other ETFs, options, and stocks.About JUNS
Jupiter Neurosciences, Inc. is a clinical-stage pharmaceutical company engaged in treating neuroinflammation with a current focus on CNS disorders and rare diseases. The firm offers JOTROL, an enhanced orally administered resveratrol formulation, designed to deliver therapeutically relevant, safe levels of resveratrol.
JUNS Key Statistics
Stock Snapshot
Jupiter Neurosciences(JUNS) stock is priced at $2.81, giving the company a market capitalization of 3.71M. It carries a P/E multiple of -0.14.
On 2026-10-09, Jupiter Neurosciences(JUNS) stock moved within a range of $2.67 to $2.89. With shares now at $2.81, the stock is trading +5.2% above its intraday low and -2.8% below the session's peak.
Trading activity shows a volume of 4.28K, compared to an average daily volume of 119.66K.
Over the past 52 weeks, Jupiter Neurosciences(JUNS) stock has traded between a high of $135.75 and a low of $2.25.
Over the past 52 weeks, Jupiter Neurosciences(JUNS) stock has traded between a high of $135.75 and a low of $2.25.
JUNS News
Jupiter Neurosciences (JUNS) announced that the first patient has been dosed in the company’s Phase 2a RESET clinical trial evaluating JOTROL in patients with P...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.